Literature DB >> 6107091

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.

K Swedberg, A Hjalmarson, F Waagstein, I Wallentin.   

Abstract

Fifteen patients with congestive cardiomyopathy who had improved conspicuously on chronic administration of a beta-blocker were studied after withdrawal of the drug. In six patients there was a pronounced deterioration of their clinical condition, and in all of the remaining patients there was a significant decrease in ejection fraction, and signs of compromised diastolic function with pathological apex curves and an increase in third heart sound. All these changes were reversed within a few weeks to a few months after readministration of beta-blocking drugs. This study supports the idea that an aetiological factor in congestive cardiomyopathy may be a pathological response to sympathetic stimulation which could be partly controlled by administration of beta-blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107091      PMCID: PMC482372          DOI: 10.1136/hrt.44.2.134

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  10 in total

1.  CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE.

Authors:  C A CHIDSEY; E BRAUNWALD; A G MORROW
Journal:  Am J Med       Date:  1965-09       Impact factor: 4.965

2.  In vitro effects of catecholamines on protein synthesis in perfused rat heart.

Authors:  B J Källfelt; A C Hjalmarson; O G Isaksson
Journal:  J Mol Cell Cardiol       Date:  1976-10       Impact factor: 5.000

3.  Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.

Authors:  G Johnsson; L Jordö; P Lundborg; O Rönn; I Welin-Fogelberg; J Wikstrand
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

4.  Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.

Authors:  R R Miller; H G Olson; E A Amsterdam; D T Mason
Journal:  N Engl J Med       Date:  1975-08-28       Impact factor: 91.245

5.  Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Authors:  K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal:  Lancet       Date:  1979-06-30       Impact factor: 79.321

6.  Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents.

Authors:  R Ariniego; F Waagstein; B Mombay; A Hjalmarson
Journal:  Br Heart J       Date:  1979-08

7.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

Authors:  F Waagstein; A Hjalmarson; E Varnauskas; I Wallentin
Journal:  Br Heart J       Date:  1975-10

8.  Mechanism of propranolol withdrawal phenomena.

Authors:  S Nattel; R E Rangno; G Van Loon
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

9.  Hemodynamic and metabolic response after abrupt uithdrawal of long-term propranolol.

Authors:  J H Myers; L D Horwitz
Journal:  Circulation       Date:  1978-08       Impact factor: 29.690

10.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.

Authors:  K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal:  Br Heart J       Date:  1980-08
  10 in total
  31 in total

Review 1.  Centrally acting sympatholytic agents in the treatment of congestive heart failure. A review of the literature.

Authors:  A Manmontri; S M MacLeod
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

Review 2.  Therapy of idiopathic dilated cardiomyopathy with chronic beta-adrenergic blockade.

Authors:  E M Gilbert; J B O'Connell; M R Bristow
Journal:  Heart Vessels Suppl       Date:  1991

Review 3.  Beta-blocker use in decompensated heart failure.

Authors:  Rami Alharethi; Ray E Hershberger
Journal:  Curr Heart Fail Rep       Date:  2006-06

4.  History of Beta blockers in congestive heart failure.

Authors:  K Swedberg
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 5.  Choosing the right beta-blocker. A guide to selection.

Authors:  J R Hampton
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

Review 6.  Myocardial beta-adrenoceptor function and regulation in heart failure: implications for therapy.

Authors:  D B Barnett
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

7.  Dobutamine stress echocardiography for the detection of myocardial viability in patients with left ventricular dysfunction taking beta blockers: accuracy and optimal dose.

Authors:  T Zaglavara; R Haaverstad; B Cumberledge; T Irvine; H Karvounis; G Parharidis; G Louridas; A Kenny
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

8.  Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.

Authors:  S J Virk; M K Davies
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 9.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 10.  Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives.

Authors:  Bernhard Maisch; Sabine Pankuweit
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.